These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 36058508)

  • 1. Valproic acid induced liver injury: An insight into molecular toxicological mechanism.
    Ezhilarasan D; Mani U
    Environ Toxicol Pharmacol; 2022 Oct; 95():103967. PubMed ID: 36058508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Butyrate prevents valproate-induced liver injury: In vitro and in vivo evidence.
    Pirozzi C; Lama A; Annunziata C; Cavaliere G; De Caro C; Citraro R; Russo E; Tallarico M; Iannone M; Ferrante MC; Mollica MP; Mattace Raso G; De Sarro G; Calignano A; Meli R
    FASEB J; 2020 Jan; 34(1):676-690. PubMed ID: 31914696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic activation of unsaturated derivatives of valproic acid. Identification of novel glutathione adducts formed through coenzyme A-dependent and -independent processes.
    Kassahun K; Hu P; Grillo MP; Davis MR; Jin L; Baillie TA
    Chem Biol Interact; 1994 Mar; 90(3):253-75. PubMed ID: 8168173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sodium valproate induces mitochondrial respiration dysfunction in HepG2 in vitro cell model.
    Komulainen T; Lodge T; Hinttala R; Bolszak M; Pietilä M; Koivunen P; Hakkola J; Poulton J; Morten KJ; Uusimaa J
    Toxicology; 2015 May; 331():47-56. PubMed ID: 25745980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluorinated analogues as mechanistic probes in valproic acid hepatotoxicity: hepatic microvesicular steatosis and glutathione status.
    Tang W; Borel AG; Fujimiya T; Abbott FS
    Chem Res Toxicol; 1995; 8(5):671-82. PubMed ID: 7548749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential relationships between transaminase abnormality and valproic acid clearance or serum carnitine concentrations in Japanese epileptic patients.
    Goto S; Seo T; Hagiwara T; Ueda K; Yamauchi T; Nagata S; Ando Y; Ishitsu T; Nakagawa K
    J Pharm Pharmacol; 2008 Feb; 60(2):267-72. PubMed ID: 18237476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of valproic acid on the expression of various acyl-CoA dehydrogenases in rats.
    Kibayashi M; Nagao M; Chiba S
    Pediatr Int; 1999 Feb; 41(1):52-60. PubMed ID: 10200137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Valproic Acid and the Liver Injury in Patients with Epilepsy: An Update.
    Guo HL; Jing X; Sun JY; Hu YH; Xu ZJ; Ni MM; Chen F; Lu XP; Qiu JC; Wang T
    Curr Pharm Des; 2019; 25(3):343-351. PubMed ID: 30931853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of hepatic carnitine palmitoyl-transferase I (CPT IA) by valproyl-CoA as a possible mechanism of valproate-induced steatosis.
    Aires CC; Ijlst L; Stet F; Prip-Buus C; de Almeida IT; Duran M; Wanders RJ; Silva MF
    Biochem Pharmacol; 2010 Mar; 79(5):792-9. PubMed ID: 19854160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carnitine in the treatment of valproic acid-induced toxicity.
    Lheureux PE; Hantson P
    Clin Toxicol (Phila); 2009 Feb; 47(2):101-11. PubMed ID: 19280426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subchronic effects of valproic acid on gene expression profiles for lipid metabolism in mouse liver.
    Lee MH; Kim M; Lee BH; Kim JH; Kang KS; Kim HL; Yoon BI; Chung H; Kong G; Lee MO
    Toxicol Appl Pharmacol; 2008 Feb; 226(3):271-84. PubMed ID: 17963808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The serum acylcarnitines profile in epileptic children treated with valproic acid and the protective roles of peroxisome proliferator-activated receptor
    Ma Y; Wang M; Guo S; Li T; Liu X; Zhao L
    Front Pharmacol; 2022; 13():1048728. PubMed ID: 36425583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxidative stress as a mechanism of valproic acid-associated hepatotoxicity.
    Chang TK; Abbott FS
    Drug Metab Rev; 2006; 38(4):627-39. PubMed ID: 17145692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversal of the adverse chronic effects of the unsaturated derivative of valproic acid--2-n-propyl-4-pentenoic acid--on ketogenesis and liver coenzyme A metabolism by a single injection of pantothenate, carnitine, and acetylcysteine in developing mice.
    Thurston JH; Hauhart RE
    Pediatr Res; 1993 Jan; 33(1):72-6. PubMed ID: 8433865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new approach on valproic acid induced hepatotoxicity: involvement of lysosomal membrane leakiness and cellular proteolysis.
    Pourahmad J; Eskandari MR; Kaghazi A; Shaki F; Shahraki J; Fard JK
    Toxicol In Vitro; 2012 Jun; 26(4):545-51. PubMed ID: 22342442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aspects of long-chain acyl-COA metabolism.
    Tol VA
    Mol Cell Biochem; 1975 Apr; 7(1):19-31. PubMed ID: 1134497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative systems pharmacology Model to characterize valproic acid-induced hyperammonemia and the effect of L-carnitine supplementation.
    Schiavo A; Maldonado C; Vázquez M; Fagiolino P; Trocóniz IF; Ibarra M
    Eur J Pharm Sci; 2023 Apr; 183():106399. PubMed ID: 36740101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Valproic acid metabolism and its effects on mitochondrial fatty acid oxidation: a review.
    Silva MF; Aires CC; Luis PB; Ruiter JP; IJlst L; Duran M; Wanders RJ; Tavares de Almeida I
    J Inherit Metab Dis; 2008 Apr; 31(2):205-16. PubMed ID: 18392741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of valproic acid-induced Fanconi syndrome involves mitochondrial dysfunction and oxidative stress in rat kidney.
    Heidari R; Jafari F; Khodaei F; Shirazi Yeganeh B; Niknahad H
    Nephrology (Carlton); 2018 Apr; 23(4):351-361. PubMed ID: 28141910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of valproate and E-2-en-valproate on functional and morphological parameters of rat liver. I. Biochemical, histopathological and pharmacokinetic studies.
    Löscher W; Wahnschaffe U; Hönack D; Wittfoht W; Nau H
    Epilepsy Res; 1992 Dec; 13(3):187-98. PubMed ID: 1493781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.